Picture of Epigenomics AG logo

ECX — Epigenomics AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Epigenomics Postpones AGM, Comments On Coronavirus Impact

March 17 (Reuters) - Epigenomics AG  ECXn.DE :
    * DGAP-NEWS: EPIGENOMICS ANNOUNCES POSTPONEMENT OF ANNUAL GENERAL MEETING DUE TO CORONAVIRUS
AND
PRELIMINARY 2019 FLASH FINANCIAL RESULTS
    * EPIGENOMICS AG - COMPANY EXPECTS NEXT COUPLE OF WEEKS AND POTENTIALLY MONTHS TO REMAIN
FLUID
    * EPIGENOMICS AG - ALSO DECIDED TO MOVE RELEASE OF FULL YEAR 2019 RESULTS FROM MARCH 27,
2020 TO
APRIL 29, 2020
    * EPIGENOMICS AG - NOTES YEAR-END FLASH FINANCIAL RESULTS (UNAUDITED) WERE REVENUE OF EUR
1.1
MILLION, ADJUSTED EBITDA OF EUR -13.3 MILLION AND CASH BURN OF EUR -13.5 MILLION
    * EPIGENOMICS AG - LOOKS FORWARD TO PROVIDING A FULL YEAR-END FINANCIAL UPDATE ON APRIL 29,
2020
    * EPIGENOMICS AG - BELIEVES THAT IMPACT OF CORONAVIRUS PANDEMIC ON ITS 2020 REVENUE SHOULD
BE
NEGLIGIBLE
    * EPIGENOMICS AG - ISSUANCE OF A POSITIVE COVERAGE DECISION WOULD RESULT IN ONLY ONE MONTH
OF
REIMBURSEMENT IN 2020
    * EPIGENOMICS AG - EXECUTIVE BOARD ASSUMES THAT REALIZATION OF COMMERCIAL TEST VOLUME AND
REVENUE
RAMP WILL OCCUR IN 2021

Source text for Eikon:  ID:nEQbwqQ8ba 
Further company coverage:  ECXn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Epigenomics AG

See all news